• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON CARIBE LTD. BD MACRO-VUE¿ RPR CARD TEST; ANTIGENS, NONTREPONEMAL, ALL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON CARIBE LTD. BD MACRO-VUE¿ RPR CARD TEST; ANTIGENS, NONTREPONEMAL, ALL Back to Search Results
Model Number 275005
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/04/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during use with the bd macro-vue¿ rpr card test, erroneous results were obtained.Erroneous results were reported to the clinician, but there was no patient impact.The following information was provided by the initial reporter: the negative control is again cloudy and also some of the sample so it is difficult to decide if the sample is positive or negative.The agglutination reagent have the same lot number in all kits.When you look at the tubes in the kits the liquid is with sedimentation /granular in it and it differs how much sedimentation is between tubes.
 
Additional Manufacturer Narrative
Initial reporter phone number: (b)(6).A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Additional Manufacturer Narrative
Clarifying information provided by the initial reporter indicates that because of the issue with the negative control, the results were not considered valid and were not reported to a clinician.Testing was repeated with a new lot.The previous mfr report #2647876-2022-00230 should be considered canceled.
 
Event or Problem Description
It was reported that during use with the bd macro-vue¿ rpr card test, erroneous results were obtained.Erroneous results were reported to the clinician, but there was no patient impact.The following information was provided by the initial reporter: the negative control is again cloudy and also some of the sample so it is difficult to decide if the sample is positive or negative.The agglutination reagent have the same lot number in all kits.When you look at the tubes in the kits the liquid is with sedimentation /granular in it and it differs how much sedimentation is between tubes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MACRO-VUE¿ RPR CARD TEST
Common Device Name
ANTIGENS, NONTREPONEMAL, ALL
Manufacturer (Section D)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer (Section G)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15901602
Report Number2647876-2022-00230
Device Sequence Number12030047
Product Code GMQ
UDI-Device Identifier00382902750055
UDI-Public(01)00382902750055
Combination Product (Y/N)N
Initial Reporter CountryIC
PMA/510(K) Number
NA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date04/30/2024
Device Model Number275005
Device Catalogue Number275005
Device Lot Number2094445
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/04/2022
Supplement Date Received by Manufacturer12/20/2022
Initial Report FDA Received Date12/02/2022
Supplement Report FDA Received Date01/04/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/10/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-